📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Simvastatin in Critically Ill Patients with Covid-19. (2023)

First Author: REMAP-CAP Investigators

Attributed to: Hydroxymethylglutaryl-CoA reductase inhibition with simvastatin in Acute lung injury to Reduce Pulmonary dysfunctio funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1056/nejmoa2309995

PubMed Identifier: 37888913

Publication URI: http://europepmc.org/abstract/MED/37888913

Type: Journal Article/Review

Volume: 389

Parent Publication: The New England journal of medicine

Issue: 25

ISSN: 0028-4793